Press Releases

01.08.2016

Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations

01.08.2016

Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions

01.07.2016

PHILOGEN ANNOUNCES EXERCISE OF OPTIONS WITHIN THE LICENSE AGREEMENT WITH PFIZER INC. FOR THE DEVELOPMENT AND POTENTIAL COMMERCIALIZATION OF MULTIPLE ANTIBODY DRUG CONJUGATES (ADCs) AND TARGETED TECHNOLOGIES

01.07.2016

4D Molecular Therapeutics Announces Collaboration with Pfizer Inc. for Cardiac Gene Therapy Vector Discovery and Development

01.06.2016

Cortexyme Raises $15 Million Series A

01.06.2016

NextCure, Inc., New Immuno-Oncology Firm Announces $67 Million Series A Financing

01.04.2016

KineMed Enters Into Strategic Proteomic Biomarker Discovery Collaboration with Pfizer Inc.

01.04.2016

Absorption Systems Licenses Cell Line to Pfizer

01.04.2016

Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer

12.22.2015

Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts

12.22.2015

Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab

12.14.2015

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference